Inventiva (IVA) Return on Capital Employed (2020 - 2025)
Inventiva's (IVA) quarterly Return on Capital Employed came in at 0.37% in Q2 2025, up 129.0% year-on-year from 0.16% in Q2 2024, and down 131.56% quarter-over-quarter from 1.17% in Q4 2024.
Inventiva (IVA) Return on Capital Employed (2020 - 2025) Analysis & Trends
Inventiva's Return on Capital Employed history runs 5 years deep, the most recent figure standing at 0.37% for Q2 2025.
- On a quarterly basis, Return on Capital Employed rose 129.0% year-over-year to 0.37% in Q2 2025; TTM through Jun 2025 was 0.37%, a 129.0% increase from a year earlier, with the FY2025 full-year figure at 138.27%, down 51023.0% from the prior year.
- Return on Capital Employed retreated to 0.37% in Q2 2025 per IVA's latest filing, from 1.17% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 1.17% in Q4 2024 and bottomed at 1835.55% in Q4 2023.
- The 4-year median for Return on Capital Employed is 23.42% (2021), against an average of 322.87%.
- Across the five-year window, Return on Capital Employed soared 183673 bps in 2024 and jumped 129 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 55.61% in 2021, then sank by 3201 bps to 1835.55% in 2023, then surged by 100 bps to 1.17% in 2024, then tumbled by 132 bps to 0.37% in 2025.
- Per Business Quant, the three latest IVA Return on Capital Employed figures stand at 0.37% (Q2 2025), 1.17% (Q4 2024), and 1.66% (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -0.37% |
| Dec 31, 2024 | 1.17% |
| Jun 30, 2024 | -1.66% |
| Dec 31, 2023 | -1,835.55% |
| Jun 30, 2021 | -55.61% |
| Mar 31, 2021 | -45.19% |
| Dec 31, 2020 | -82.87% |